Greenway announces Q2 results: revenue up 12 percent, EPS $0.00 far short of analyst estimates of $0.05. Greenway has adjusted FY13 earnings guidance to $0.21-$0.28 EPS, with analysts predicting $0.27. Shares were down eight percent in Tuesday’s after-hours trading.
Following a strong reception into the critical access and community hospital EHR market, RazorInsight closes an $11 Million in Series A funding round.
Russell Branzell, CEO of the Colorado Health Medical Group, has been named president and CEO of CHIME.
Mount Sinai’s ongoing $120 million Epic implementation is credited with improved core measure performance and a reduction of readmissions by 56 percent.